1. Home
  2. GKOS vs GXO Comparison

GKOS vs GXO Comparison

Compare GKOS & GXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$107.89

Market Cap

5.4B

Sector

Health Care

ML Signal

HOLD

Logo GXO Logistics Inc.

GXO

GXO Logistics Inc.

HOLD

Current Price

$52.64

Market Cap

5.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
GKOS
GXO
Founded
1998
2021
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Transportation Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
5.4B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
GKOS
GXO
Price
$107.89
$52.64
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
13
12
Target Price
$122.08
$61.00
AVG Volume (30 Days)
1.1M
1.2M
Earning Date
10-29-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.76
Revenue
$469,820,000.00
$12,921,000,000.00
Revenue This Year
$30.89
$13.31
Revenue Next Year
$24.36
$5.86
P/E Ratio
N/A
$69.01
Revenue Growth
30.38
16.94
52 Week Low
$73.16
$30.46
52 Week High
$163.71
$60.65

Technical Indicators

Market Signals
Indicator
GKOS
GXO
Relative Strength Index (RSI) 73.56 57.41
Support Level $104.11 $50.06
Resistance Level $107.18 $50.88
Average True Range (ATR) 4.40 1.54
MACD 1.26 0.48
Stochastic Oscillator 92.97 93.87

Price Performance

Historical Comparison
GKOS
GXO

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About GXO GXO Logistics Inc.

GXO Logistics Inc is a contract logistics company. Its revenue is diversified across numerous verticals and customers, including many multinational corporations. It provides warehousing and distribution, order fulfillment, e-commerce, reverse logistics, and other supply chain services differentiated by its ability to deliver technology-enabled, customized solutions at scale. Geographically, it generates revenue from the United Kingdom, the United States, the Netherlands, France, Spain, Italy, and other countries, and derives the majority of its revenue from the United Kingdom.

Share on Social Networks: